Sign in

Roman-Ulrich Müller

@muellerrom.bsky.social
107 followers 21 following 78 posts

passionate for translational research...kidney disease and beyond...

PostsRepliesMedia
Reposted by Roman-Ulrich Müller
PKD International @pkdinternational.bsky.social · 05/10/2026
🧵🌍 A new milestone for the STOP-PKD Study. Fundació Puigvert Barcelona has officially become the first active STOP-PKD trial site in Spain. This is an important step forward for the study and for the international effort to advance research in ADPKD.
121
Reposted by Roman-Ulrich Müller
CRC1678 @crc1678.bsky.social · 02/10/2026
🚨 Publication Alert 🚨 New @cp-cellreports.bsky.social paper from #CRC1678 member @muellerrom.bsky.social maps real‑time kidney metabolic responses. Oxidative stress triggers rapid rewiring, and amino acids enhance antioxidative defenses in a sex‑dependent manner. 🥳 👉 doi.org/10.1016/j.ce...
doi.org
Redirecting
021
Reposted by Roman-Ulrich Müller
PKD International @pkdinternational.bsky.social · 09/09/2026
🧵🧪 STOP-PKD study | Five additional trial sites successfully initiated The STOP-PKD study continues to expand its network across Europe, with five additional trial sites now successfully initiated in the Netherlands, Germany and Austria.
111
Reposted by Roman-Ulrich Müller
Andreas Beyer Group @beyerlab.bsky.social · 21/08/2026
Paper out on single-cell damage scores.📜Quantify the damage of single podocytes or hepatocytes using their transcriptomes to study degenerative diseases. Big congrats to the Beyer-Lab members Tim Padvitski and Paula Unger 🍾🌟🎉 Thanks to all the fantastic collaborators! www.cell.com/cell-genomic...
cell.com
Cell-type-specific damage scores reveal kidney and liver disease trajectories in single-cell and spatial transcriptomics
Padvitski, Unger Avila, Chen et al. introduce a single-cell transcriptomic framework that quantifies progressive cellular damage across degenerative disease models. Applied to kidney and liver injury,...
172
Reposted by Roman-Ulrich Müller
PKD International @pkdinternational.bsky.social · 25/08/2026
🧵⏳ 10 days to go | 1st PKD Global Members Meeting In just 10 days, leaders from PKD International member organisations will come together in Leuven, Belgium, for the first PKD Global Members Meeting.
121
Reposted by Roman-Ulrich Müller
Universität zu Köln @unicologne.bsky.social · 21/08/2026
🔬Forschende @beyerlab.bsky.social @cecad.bsky.social haben eine Methode entwickelt, um altersbedingte degenerative Erkrankungen auf Zellebene zu untersuchen. Erstmals lassen sich Schäden präzise quantifizieren ermöglicht damit Krankheitsverläufe in Gewebeproben zu analysieren➡️https://uni.koeln/HKPYE
Mehrere blaue Zellen mit sichtbarem Zellkern schweben vor unscharfem blauem Hintergrund.
052
Reposted by Roman-Ulrich Müller
Universität zu Köln @unicologne.bsky.social · 21/08/2026
🔬Researchers @beyerlab.bsky.social @cecad.bsky.social developed a method that enables damage to individual cells to be precisely quantified. It uses molecular markers and enables the detailed analysis of disease progression in individual tissue samples, such as a biopsy ➡️ uni.koeln/W5DU7
Mehrere blaue Zellen mit sichtbarem Zellkern schweben vor unscharfem blauem Hintergrund.
083
Reposted by Roman-Ulrich Müller
CRC1678 @crc1678.bsky.social · 20/08/2026
🚨 Publication Alert 🚨 New study from #CRC1678 members @beyerlab.bsky.social and @muellerrom.bsky.social maps kidney and liver disease using cell‑type‑specific damage scores. PDS/HDS track cell injury and reveal circadian disruption and a MASLD/NASH threshold. 🍾🥳 👉 www.cell.com/cell-genomic...
cell.com
Cell-type-specific damage scores reveal kidney and liver disease trajectories in single-cell and spatial transcriptomics
Padvitski, Unger Avila, Chen et al. introduce a single-cell transcriptomic framework that quantifies progressive cellular damage across degenerative disease models. Applied to kidney and liver injury,...
064
Reposted by Roman-Ulrich Müller
MPI for Biology of Ageing @mpiage.bsky.social · 10/08/2026
📢 Publication alert New study from the @antebilab.bsky.social on Verheij syndrome, a rare genetic developmental disorder linked to defects in RNA splicing. www.nature.com/articles/s41...
nature.com
Vitamin B12 alleviates spliceosomopathy via phospholipid remodeling - Nature Communications
The authors use a Caenorhabditis elegans model of Verheij syndrome, caused by mutations in the splicing factor PUF60, and show that Vitamin B12 can rescue the phenotype.
084
Reposted by Roman-Ulrich Müller
Radiology: Artificial Intelligence @radiology-ai.bsky.social · 09/08/2026
An iterative training approach, the expert-guided annotation loop, for efficient reference standard medical image segmentation doi.org/10.1148/ryai.250200 @muellerrom.bsky.social #Segmentation #ML #MachineLearning
Image from article in Radiology: Artificial Intelligence
051
Reposted by Roman-Ulrich Müller
PKD International @pkdinternational.bsky.social · 30/07/2026
🧵🧪 STOP-PKD study | Four additional trial sites activated The STOP-PKD study continues to expand its recruitment network across Europe, with four additional trial sites now initiated: three in Germany and a second centre in Austria.
141
Roman-Ulrich Müller @muellerrom.bsky.social · 24/07/2026
Wir suchen hoch motivierte Kolleg*innen, die Spaß daran haben unser interdisziplinäres Team zu ergänzen. Eine herausfordernde Position, mit der wir gemeinsam die nächsten Schritte in die Zukunft der Klinik für Nephrologie gehen möchten. Ich freue mich auf die Zusammenarbeit!
000
Roman-Ulrich Müller @muellerrom.bsky.social · 24/07/2026
Unterstützung im Direktions- und Oberarztsekretariat gesucht! Eine herausragende administrative Organisation ist die Voraussetzung für eine wissenschaftlich starke Nephrologie an einem Universitätsklinikum. www.uniklinik-duesseldorf.de/ausbildung-k... www.uniklinik-duesseldorf.de/ausbildung-k...
uniklinik-duesseldorf.de
Detailseite
100
Roman-Ulrich Müller @muellerrom.bsky.social · 24/07/2026
Embedded in a unique research environment between clinician-scientists, molecular research labs at the Nephrology Department and the data science research environment of the Center for Digital Medicine (www.zdm.hhu.de/en/) this group will make a central contribution to the kidney disease field.
zdm.hhu.de
Center for Digital Medicine (CDM)
000
Roman-Ulrich Müller @muellerrom.bsky.social · 24/07/2026
Great opening for a professorship on data science in kidney disease and transplantation. Making the next steps towards targeted treatment in nephrology will largely depend on data science. Looking forward to working on this transition together with outstanding colleagues. bit.ly/3TlscBM
bit.ly
110
Reposted by Roman-Ulrich Müller
Radiology: Artificial Intelligence @radiology-ai.bsky.social · 16/07/2026
An expert-guided annotation loop reduced expert annotation time and enabled estimated cost savings while producing high-quality reference standard CT and MRI segmentations doi.org/10.1148/ryai.250200 @muellerrom.bsky.social #AI #ML #MachineLearning
Image from article in Radiology: Artificial Intelligence
031
Reposted by Roman-Ulrich Müller
Radiology: Artificial Intelligence @radiology-ai.bsky.social · 17/07/2026
An iterative training approach, the expert-guided annotation loop, for efficient reference standard medical image segmentation doi.org/10.1148/ryai.250200 @muellerrom.bsky.social #Segmentation #MRI #MachineLearning
Image from article in Radiology: Artificial Intelligence
032
Reposted by Roman-Ulrich Müller
Radiology: Artificial Intelligence @radiology-ai.bsky.social · 18/07/2026
An iterative training approach, the expert-guided annotation loop, for efficient reference standard medical image segmentation doi.org/10.1148/ryai.250200 @muellerrom.bsky.social #CostAnalysis #MRI #ML
Image from article in Radiology: Artificial Intelligence
041
Reposted by Roman-Ulrich Müller
Radiology: Artificial Intelligence @radiology-ai.bsky.social · 06/07/2026
An iterative training approach, the expert-guided annotation loop, for efficient reference standard medical image segmentation doi.org/10.1148/ryai.250200 @muellerrom.bsky.social #MRI #AI #ML
Image from article in Radiology: Artificial Intelligence
041
Roman-Ulrich Müller @muellerrom.bsky.social · 03/07/2026
Interested in working on RNA-biology in human disease? We can offer a PhD student position in a great team. Looking into RNA-modifications as a driver of polycystic kidney disease together with @landthalerm.bsky.social www.jobvector.de/job/phd-stud...
jobvector.de
PhD Student*in (m/w/d) | Job in Düsseldorf
Conducting innovative research in line with the above-mentioned project. Collecting, analyzing, and interpreting data using various OMICs techniques. Conducting in vitro and in vivo experiments. Colla...
031
Reposted by Roman-Ulrich Müller
Radiology: Artificial Intelligence @radiology-ai.bsky.social · 26/06/2026
Impact on Cost and Expert Time of Data-Efficient Deep Learning for Medical Image Segmentation doi.org/10.1148/ryai.250200 @muellerrom.bsky.social #Segmentation #AI #MachineLearning
Image from article in Radiology: Artificial Intelligence
042
Reposted by Roman-Ulrich Müller
Radiology: Artificial Intelligence @radiology-ai.bsky.social · 25/06/2026
An expert-guided annotation loop reduced expert annotation time and enabled estimated cost savings while producing high-quality reference standard CT and MRI segmentations doi.org/10.1148/ryai.250200 @muellerrom.bsky.social #MRI #CT #ML
Image from article in Radiology: Artificial Intelligence
031
Reposted by Roman-Ulrich Müller
PKD International @pkdinternational.bsky.social · 10/06/2026
🧵 (4/4) 🌍 Please check the map available on the study website to identify the nearest participating centre. If you need any support or guidance, we would be very happy to support you or to connect you with your local patient association. @uniklinikkoeln.bsky.social @muellerrom.bsky.social
stop-pkd.de
Home
011
Reposted by Roman-Ulrich Müller
PKD International @pkdinternational.bsky.social · 10/06/2026
🧵 🧪 STOP-PKD study | New recruitment sites Research on ADPKD continues to move forward: stop-pkd.de/en
131
Roman-Ulrich Müller @muellerrom.bsky.social · 28/05/2026
Great collaborative effort — thanks to everyone involved! www.nature.com/articles/s41... #Aging #Longevity #KidneyTransplantation #Nephrology #CalorieRestriction @cecad.bsky.social @uniklinikkoeln.bsky.social @hhu.de
nature.com
An in-depth analysis of the molecular changes induced by short-term calorie restriction before living kidney donation - npj Aging
npj Aging - An in-depth analysis of the molecular changes induced by short-term calorie restriction before living kidney donation
020
Roman-Ulrich Müller @muellerrom.bsky.social · 28/05/2026
• reduced insulin/IGF signaling • modulation of inflammatory pathways • enhanced metabolic adaptation • stress resistance mechanisms conserved across species These findings strengthen the translational bridge between longevity research and clinical nephrology/transplantation. 🧵
110
Roman-Ulrich Müller @muellerrom.bsky.social · 28/05/2026
We’re excited to share our latest publication in npj Aging on the molecular effects of short-term calorie restriction before living kidney donation. Using proteomics, lipidomics, and cytokine profiling, we found that just 7 days of 50% calorie restriction induced molecular signatures linked to: 🧵
120
Roman-Ulrich Müller @muellerrom.bsky.social · 26/05/2026
A recent survey study performed by the @ERAkidney WG Genes&Kidney addresses this question and highlights how current recommendations are implemented in real-world care. academic.oup.com
academic.oup.com
Oxford Academic
Oxford Academic
010
Roman-Ulrich Müller @muellerrom.bsky.social · 26/05/2026
The fact that primary hyperoxaluria is the first kidney disease for which an RNA therapeutic has become available is a milestone for the field. How does this change the treatment landscape? 🧵
230
Reposted by Roman-Ulrich Müller
PKD International @pkdinternational.bsky.social · 22/05/2026
🧵 🧬 ADPKD research needs your voice The future of ADPKD research is evolving — and patient perspectives are essential to guide this change.
131
Reposted by Roman-Ulrich Müller
Universität zu Köln @unicologne.bsky.social · 21/05/2026
🔬🩺 From bench to bedside Professor @olivercornely.bsky.social und Professor @muellerrom.bsky.social explain in the new #Unimagazin how Basic Research leads to medical Progress. Read more ▶️ uni.koeln/2VKJM #uniköln #unicologne #transationalresearch @cecad.bsky.social
Arzt im weißen Kittel führt ein Gespräch mit einer Patientin im Krankenhauszimmer.
065
Reposted by Roman-Ulrich Müller
Universität zu Köln @unicologne.bsky.social · 21/05/2026
🔬🩺 Aus dem Labor ans Krankenbett Wie aus Grundlagenforschung medizinischer Fortschritt wird erklären Professor @olivercornely.bsky.social und Professor @muellerrom.bsky.social im aktuellen #Unimagazin. Zum Artikel ▶️ uni.koeln/LHSE3 #uniköln #unicologne #transationalresearch @cecad.bsky.social
Arzt im weißen Kittel führt ein Gespräch mit einer Patientin im Krankenhauszimmer.
075
Reposted by Roman-Ulrich Müller
PKD International @pkdinternational.bsky.social · 19/05/2026
🧵 🧪 STOP-PKD study | Expanding recruitment across Europe: stop-pkd.de/en The STOP-PKD study continues to expand, marking an important step forward for ADPKD research in Europe.
122
Roman-Ulrich Müller @muellerrom.bsky.social · 12/05/2026
Huge thanks to all collaborators, clinicians, study nurses, researchers, data scientists — and especially the patients contributing to this effort. @uniklinikkoeln.bsky.social @unicologne.bsky.social @hhu.de @pott-ukd.bsky.social @cecad.bsky.social @pkdinternational.bsky.social
000
Roman-Ulrich Müller @muellerrom.bsky.social · 12/05/2026
More broadly, MEDA points toward: ➡️ continuously learning health systems ➡️ real-time translational research ➡️ scalable precision medicine infrastructures 📄 Preprint: doi.org/10.21203/rs.... 🖥️ Live dashboard: shiny.cecad.uni-koeln.de/ADPKD_regist...
doi.org
MEDA-PKD: A Dynamic, Real-Time Analytics Platform for Precision Care in Autosomal Dominant Polycystic Kidney Disease
Real-life medical data usage is currently limited by lack of structured databases and analysis tools. Autosomal dominant polycystic kidney disease (ADPKD) remains the most common monogenic cause of ki...
110
Roman-Ulrich Müller @muellerrom.bsky.social · 12/05/2026
One exciting finding: 📉 Real-world analyses showed ~27% slowing of kidney function decline under tolvaptan — remarkably close to pivotal trial data, highlighting the power of real-time therapeutic monitoring.
100
Roman-Ulrich Müller @muellerrom.bsky.social · 12/05/2026
🔍 Current cohort: • 1,735 ADPKD patients (and growing continuously) • 20,000+ lab measurements • longitudinal tracking of kidney function, imaging, medications & QoL • interactive dashboards for subgroup analyses & patient trajectories
100
Roman-Ulrich Müller @muellerrom.bsky.social · 12/05/2026
Instead of static registry snapshots, MEDA-PKD creates a continuously learning ecosystem integrating: • clinical routine data • imaging • laboratory values • patient-reported outcomes • proteomics & omics data —all within one harmonized interactive platform.
100
Roman-Ulrich Müller @muellerrom.bsky.social · 12/05/2026
I’ve been using the platform myself almost daily since its prefinal version went live last year, and I’m genuinely excited to finally share it with the community. 🚀 Today we present MEDA-PKD: a dynamic, real-time analytics platform for precision care in ADPKD.
100
Roman-Ulrich Müller @muellerrom.bsky.social · 12/05/2026
I usually think twice before posting preprints. But this time it’s different. MEDA-PKD is the essence of our work over more than a decade — and, to me, one of the most meaningful contributions I’ve been able to make to biomedical research. 🧵
132
Roman-Ulrich Müller @muellerrom.bsky.social · 06/05/2026
New publication on hereditary kidney tumors. Our questionnaire-based screening approach (referenced in the German giudeline) has now been validated. A step toward better identification of patients who may benefit from genetic evaluation and personalized care. 📖 academic.oup.com/ckj/advance-...
academic.oup.com
Hereditary kidney tumor syndromes: structured evaluation of a questionnaire-based approach
AbstractBackground. Up to 8% of renal tumors have a monogenic cause, yet hereditary renal cell carcinoma (hRCC) syndromes such as Von Hippel–Lindau (VHL),
020
Roman-Ulrich Müller @muellerrom.bsky.social · 02/05/2026
ADPKD comes with increased risk of aneurysms. This manifestation comes concern, for both patients and MDs. Risk assessment? Screening? Treatment decisions? This ERA Genes&Kidney commentary provides fin-depth guidance based on the @kdigo.org ADPKD guideline. academic.oup.com/ndt/article/...
academic.oup.com
KDIGO 2025 Clinical Practice Guideline for ADPKD: a commentary on intracranial aneurysms and other vascular manifestations from the ERA Working Group Genes & Kidney
Abstract. The 2025 KDIGO Clinical Practice Guideline for Autosomal Dominant Polycystic Kidney Disease (ADPKD) addresses intracranial aneurysms (ICAs) and o
0114
Reposted by Roman-Ulrich Müller
PKD International @pkdinternational.bsky.social · 17/04/2026
🧵 🧬 Help shape the future of ADPKD research Are you living with ADPKD? Your perspective matters. PKD International is part of the ARTICYST Project, a European initiative bringing together research centres and the patient community to improve the future of ADPKD research.
131
Reposted by Roman-Ulrich Müller
PKD International @pkdinternational.bsky.social · 13/04/2026
🧵We are pleased to announce that the UMCG - Universitair Medisch Centrum Groningen in the Netherlands is now officially accredited as a trial site for the STOP-PKD Study.
121
Reposted by Roman-Ulrich Müller
PKD International @pkdinternational.bsky.social · 10/04/2026
🧵🧪 Important recruitment update on the STOP-PKD study (1/6) We are very pleased to share a significant update on the #STOP-PKD study, an important European research initiative for people living with #ADPKD.
132
Reposted by Roman-Ulrich Müller
PKD International @pkdinternational.bsky.social · 07/04/2026
🧵 1/4 Living with #ADPKD? Take the survey and use your voice to shape the future of ADPKD research. 📣 survey.uni-koeln.de/index.php/31... 🪡 Read this thread 👇 #PKD #PatientVoice #OpenScience #RareDisease #KidneyHealth #HorizonEurope #European #Research
142
Reposted by Roman-Ulrich Müller
PKD International @pkdinternational.bsky.social · 02/04/2026
🧵🧪 Important recruitment update on the STOP-PKD study (1/6) We are very pleased to share a significant update on the #STOP-PKD study, an important European research initiative for people living with #ADPKD.
131
Roman-Ulrich Müller @muellerrom.bsky.social · 28/02/2026
My first rare disease day at University Hospital Düsseldorf. Great to see this is an active topic on site. Looking forward to setting up the Center for Rare and Genetic Kidney Diseases and continuing the efforts to improve patient care and research in this area. @hhu.de
020
Roman-Ulrich Müller @muellerrom.bsky.social · 24/02/2026
🚀 STOP-PKD-News! Das zweite Prüfzentrum in Mainz ist nun offiziell freigegeben. Weitere folgen (DE, NL, ES, AT). Kann SGLT2-Inhibition das Fortschreiten von Zystennieren positiv beeinflussen? Infos und Kontakte: stop-pkd.de #STOPPKD #ADPKD @pkdinternational.bsky.social @pkdgermany.bsky.social
052
Roman-Ulrich Müller @muellerrom.bsky.social · 24/02/2026
Looking forward to continuing the collaboration with @pkdinternational.bsky.social in this new position.
012